Aluminum's role in CNS-immune system interactions leading to neurological disorders

Immunome Research

Volumn 9, Issue 1, 2013, Pages

  Shaw, C A ^a   Kette, S D ^b   Davidson, R M ^c   Seneff, S ^d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Independent researcher   (United States)

^c PhyNet Inc   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Aluminium; Autoimmunity; CNS; Neurological disorders

Indexed keywords

ADJUVANT; ALUMINUM; NITRIC OXIDE SYNTHASE; PHOSPHATE; SULFATE; VACCINE; WATER;

ALUMINUM OVERLOAD; ALZHEIMER DISEASE; ANAPHYLAXIS; ARTICLE; ASTHMA; AUTISM; AUTOIMMUNE AUTOINFLAMMATORY SYNDROME INDUCED BY ADJUVANT; AUTOIMMUNE DISEASE; AUTOIMMUNITY; AUTOINFLAMMATORY DISEASE; CENTRAL NERVOUS SYSTEM; DEPRESSION; DERMATITIS; DRUG INDUCED DISEASE; DRUG USE; EOSINOPHILIC ESOPHAGITIS; HUMAN; IMMUNE SYSTEM; IMMUNOSTIMULATION; INTESTINE FLORA; MULTIPLE SCLEROSIS; NERVE CELL NECROSIS; NERVE CELL NETWORK; NEUROLOGIC DISEASE; NONHUMAN; PINEAL BODY; PREECLAMPSIA; SYNTHESIS; SYSTEMS BIOLOGY;

EID: 84896781085     PISSN: None     EISSN: 17457580     Source Type: Journal    
DOI: 10.4172/1745-7580.1000069     Document Type: Article

References (213)

1. Kurland LT (1988) Amyotrophic lateral sclerosis and Parkinson's disease complex on Guam linked to an environmental neurotoxin. Trends Neurosci 11: 51-54.
2. Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, et al (2005) Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 65: 586-590.
3. Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, et al. (2003) Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 60: 1094-1097.
4. Lieberman A, Dziatolowski M, Kupersmith M, Serby M, Goodgold A, et al. (1979). Dementia in Parkinson disease. Ann Neurol 6: 355-359.
5. Kurtz AL, Kaufer DI (2011) Dementia in Parkinson's disease. Curr Treat Options Neurol 13: 242-254.
6. Bak TH (2010) Motor neuron disease and frontotemporal dementia: One two or three diseases. Ann Indian Acad Neurol 13: S81-S88.
7. Turner MR, Goldacre R, Ramagopalan S, Talbot K, Goldacre MJ (2013). Autoimmune disease preceding amyotrophic lateral sclerosis: An epidemiologic study. Neurology 81: 1222-1225.
8. Charcot JM Lesson on diseases of the nervous system has made the Salpetriere v II Paris. Delahaye and Lecrosnier 1880: 237
9. Toyokura Y (1975) A remarkable absence of decubitus formation in patients with amyotrophic lateral sclerosis. Neurol Med Tokyo 2: 215-217.
10. Furukawa T, Toyokura Y (1976) Amyotrophic lateral sclerosis and bedsores. Lancet 1: 862.
11. Toyokura Y (1977) Amyotrophic lateral sclerosis: A clinical and pathological study on the negative features of the disease. Japan J Med 16: 269-273.
12. Ono S, Toyokura Y, Mannen T, Ishibashi Y (1988) Delayed return phenomenon in amyotrophic lateral sclerosis. Acta Neurol Scand 77: 102-107.
13. Ono S, Yamauchi M (1993) Collagen fibril diameter and its relation to cross-linking of collagen in the skin of patients with amyotrophic lateral sclerosis. J Neurol Sci 119: 74-8.
14. Fang L, Huber-Abel F, Teuchert M, Hendrich C, Dorst J, et al. (2009) Linking neuron and skin matrix metalloproteinases in amyotrophic lateral sclerosis (ALS). J Neurol Sci 285: 62-66.
15. Kihira T, Yoshida S, Kondo T, Yase Y, Ono S (2004) ALS-like skin changes in mice on a chronic low-Ca/Mg high-Al diet. J Neurol Sci 219: 7-14.
16. Ismail K, Lewis G (2006) Multi-symptom illnesses, unexplained illness and Gulf War Syndrome. Phil Trans R Soc B 361: 543-551.
17. Pall ML (2007) Explaining unexplained illnesses: Disease paradigm for chronic fatigue syndrome, multiple chemical sensitivity fibromyalgia post-traumatic stress disorder gulf war syndrome and others. Psychology Press, USA.
18. Blaylock RL (2004) Chronic microglial activation and excitotoxicity secondary to excessive immune stimulation Possible factors in Gulf War Syndrome and autism. J Am Physc Surg 9: 47-51.
19. Shaw CA, Seneff S, Kette SD, Tomljenovic L, Oller, JW et al. (2013) Aluminum-induced entropy in biological systems. Implications for neurological disease.
20. Besedovsky HO, A del Rey A (2008) Brain cytokines as integrators of the immune-neuroendocrine network. In: Handbook of Neurochemistry and Molecular Neurobiology, Lajtha A (Ed.) (3rd Edn).
21. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES (2000) The sympathetic nerve an integrative interface between two super systems: The brain and the immune system. Pharmacol Rev 52: 595-638.
22. Deverman BE, Patterson PH (2009) Cytokines and CNS Development. Neuron 64: 61-78.
23. Niebroj-Dobosz I, Jamrozik Z, Janik P, Hausmanowa-Petrusewicz I, Kwiecinski H (1999) Anti-neural antibodies in serum and cerebrospinal fluid of amyotropic lateral sclerosis (ALS) patients. Acta Neurol Scand 100: 238-243.
24. Rentzos M, Rombos A, Nikolaou C, Zoga M, Zouvelou V, et al (2010) Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: A reflection of Th17 cells activation. Neuro Scand 122: 425-429.
25. Li Y, Liu L, Barger SW, Griffin WST (2003) Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J Neurosci 23: 1605-1622.
26. Li B, Liu XY, Li Z, Bu H, Sun MM, et al. (2008) Effect of ALS IgG on motor neurons in organotypic spinal cord cultures. Can J Neurol Sci 35: 220-225.
27. Gonzalez LE, Kotler ML, Vattino LG, Conti E, Reisin RC, et al. (2011) Amyotrophic lateral sclerosis-immunoglobulins selectively interact with neuromuscular junctions expressing P/Q-type calcium channels. J Neurochem 119: 826-838.
28. Griffin WST, Ling L, Li Y, Mrak RE, Barger SW (2006) Interleukin-1 mediates Alzheimer and Lewy body pathologies. J Neuroinflam 3: 5.
29. Griffin WST, Sheng JG, Roberts GW, Mrak RE (1995) Interleukin-1 expression in different plaque types in Alzheimers disease significance in plaque evolution. J Neuropath Exp Neurol 54: 276-281.
30. Griffin WST, Stanley LC, Ling C, White L, Macleod V, et al. (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. PNAS USA 86: 7611-7615.
31. Goldgaber D, Harris HW, Hla T, Maciag T, Donnelly RJ, et al. (1989) Interleukin 1 regulates synthesis of amyloid β-protein precurson mRNA in human endothelial cells. PNAS USA 86: 7606-7610.
32. Pagani MR, Gonzalez LE, Uchitel OD (2011) Autoimmunity in amyotropic lateral sclerosi past and present. Neurol Res Intl 497080.
33. Markle JGM, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, et al. (2013) Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339: 1084-1088.
34. Olsson T (1992) Cytokines in neuroinflammatory disease role of myelin autoreactive T cell production of interferon-gamma. J Neuroimmunol 40: 211-218.
35. Stinissen P, Medaer R, Raus J (1998) Myelin reactive T cells in the autoimmune pathogenesis of multiple sclerosis. Mult Scler 4: 203-211.
36. Gran B, Hemmer B, Vergelli M, McFarland HF, Martin R (1999) Molecular mimicry and multiple sclerosis Degenerate T-cell recognition and the induction of autoimmunity. Ann Neurol 45: 559-67.
37. Westall FC (2006) Molecular mimicry revisited Gut bacteria and multiple sclerosis. J Clin Microbiol 44: 2099.
38. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, et al. (1979) Guillain-Barre syndrome following vaccination in the national influenza immunization program United States 1976-1977. Am J Epidemiol 110: 105-123.
39. Oh SJ (2001) Color atlas of nerve biopsy pathology, Toxic Neuropathies. Taylor & Francis, Boca Raton, Florida, USA.
40. Fenichel GM (1982) Neurological complications of immunization. Ann Neurol 12: 119-128.
41. Shoenfeld Y (2011) ASIA-autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 36: 4-8.
42. Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y (2009) Vaccines and autoimmunity. Nature Rev Rheumatol 5: 648-652.
43. Gherardi RK, Coquet M, Cherin P, Belec L, Moretto P, et al. (2001) Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain 124: 1821-1831.
44. Partinen M, Saarenpää-Heikkilä O, Ilveskoski I, Hublin C, Linna M, et al. (2012) Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 Pandemic vaccination campaign in Finland. PLoS ONE 7: e33723.
45. Nohynek H, Jokinen J, Partinen M, Vaarala O, Kirjavainen T, et al. (2012) AS03 Adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS ONE 7: e33536.
46. Glenny AT, Pope CG, Waddington H, Wallace UJ (1926) The antigenic value of toxoid precipitated by potassium alum. J Path Bact 29: 31-40.
47. Batista-Duharte A, Lindblad EB, Oviedo-Orta E (2011) Progress in understanding adjuvant immunotoxicity mechanisms. Toxicol Lett 203: 97.
48. Hogenesch H (2012) Mechanism of immunopotentiation and safety of aluminum adjuvants. Front Immunol 3: 406.
49. Petrik MS, Wong MC, Tabata RC, Garry RF, Shaw CA (2007) Aluminum adjuvant linked to Gulf War illness induces motor neuron death in mice. Neuromolecular Med 9: 83-100.
50. Hill AB (1965) The environment and disease Association or causation. Proc Royal Soc Med 58: 295-300.
51. Tomljenovic L, Shaw CA (2011) Aluminum vaccine adjuvants are they safe. Curr Med Chem 18: 2630-2637.
52. Mitkus RJ, King DB, Hess MA, Forshee RA, Walderhaug MO (2011) Updated aluminum pharmacokinetics following infant exposures through diet and vaccination. Vaccine 29: 9538-9543.
53. Priest N (2004) The biological behaviour and bioavailability of aluminium in man, with special reference to studies employing aluminium-26 as a tracer review and study update. J Environ Monit 6: 375-403.
54. Flarend R, Hem S, White J, Elmore D, Suckow M, et al. (1997) In vivo absorption of aluminium-containing vaccine adjuvants using 26Al. Vaccine 15: 1314-1318.
55. Khan Z, Combadiere C, Authier FJ, Itier V, Lux F, et al. (2013) Slow CCL2-dependent translocation of biopersistent particles from muscle to brain. BMC Med 11: 99.
56. Ganrot PO (1986) Metabolism and possible health effects of aluminum. Environ Health Perspect. 65: 363-441.
57. Kojima S, Hama Y, Sasaki T, Kubodera A (1983) Elevated uptake of 67Ga and increased heparan sulfate content in liver-damaged rats. Eur J Nucl Med 8: 52-59.
58. Hama Y, Sasaki T, Kojima S, Kubodera A (1984) 67Ga accumulation and heparan sulfate metabolism in lysosomes. Eur J Nucl Med 9: 51-56.
59. Ando A, Ando I, Hiraki T, Hisada K (1985) 67Ga-binding substances in stomach, small intestine, pancreas, and muscle. Eur J Nucl Med 11: 235-239.
60. Smith K, Borchardt R (1989) Permeability and mechanism of albumin, cationized albumin, and glycosylated albumin transcellular transport across monolayers of cultured bovine brain capillary endothelial cells. Pharm Res 6: 466-473.
61. Fischer D, Bieber T, Brüsselbach S, Elsässer H, Kissel T (2001) Cationized human serum albumin as a non-viral vector system for gene delivery? Characterization of complex formation with plasmid DNA and transfection efficiency. Int J Pharm 225: 97-111.
62. Hervé F, Ghinea N, Scherrmann JM (2008) CNS delivery via adsorptive transcytosis. AAPS J 10: 455-472.
63. Debiec H, Lefeu F, Kemper MJ, Niaudet P, Deschênes G, et al. (2011) Early-childhood membranous nephropathy due to cationic bovine serum albumin. N Engl J Med 364: 2101-2110.
64. Movsas TZ, Paneth N, Rumbeiha W, Zyskowski J, Gewolb IH (2013) Effect of routine vaccination on aluminum and essential element levels in preterm infants. JAMA Pediatr 167: 870-872.
65. Tomljenovic L, Shaw CA (2011) Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? J Inorg Biochem 105: 1489-1499.
66. Pollack GH (2013) The fourth phase of water: Beyond solid, liquid, and vapor. Ebner & Sons, Seattle, WA.
67. Bak P, Tang C, Wiesenfeld K (1987) Self-organized criticality: An explanation of the 1/f noise. Phys Rev Lett 59: 381-384.
68. Pal SK, Zewail AH (2004) Dynamics of water in biological recognition. Chem Rev 104: 2099-2123.
69. Johansson B, Sukhotskaya S (2012) Allometric scaling behavior-A quantum dissipative state implies a reduction in thermal infrared emission and fractal ordering in distilled coherent water. Water 3: 100-121.
70. Kadanoff LP (1986) Fractals: Where's the Physics? Physics Today 39: 6-7.
71. Davidson RM, Lauritzen A, Seneff S (2013) Biological water dynamics and entropy: A biophysical origin of cancer and other diseases. Entropy 15: 3822-3876.
72. Davidson R, Seneff S (2012) The initial common pathway of inflammation, disease, and death. Entropy 14: 1399-1442.
73. Geckeler KE, Rupp F, Geis-Gerstorfer J (1997) Interfaces and interphases of (bio)materials: Definitions, structures, and dynamics. Adv Mater 9: 513-518.
74. Taylor TJ, Hartley C, Simon PL, Kiss IZ, Berthouze L (2013) Identification of criticality in neuronal avalanches: I. A Theoretical investigation of the non-driven case. J Math Neurosci 3: 5.
75. Beggs JM, Plenz D (2003) Neuronal avalanches in neocortical circuits. J Neurosci 23: 11167-11177.
76. Hartley C, Taylor T, Kiss I, Farmer S, Berthouze L (2013) Identification of criticality in neuronal avalanches: II. A Theoretical and Empirical Investigation of the Driven Case.
77. Abel DL, Trevors JT (2006) Self-organization vs. self-ordering events in life-origin models. Phys Life Rev 3: 211-228.
78. Paczuski M, Maslov S, Bak P (1996) Avalanche dynamics in evolution, growth, and depinning models. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics 53: 414-443.
79. Palva JM, Zhigalov A, Hirvonen J, Korhonen O, Linkenkaer-Hansen K, et al. (2013) Neuronal long-range temporal correlations and avalanche dynamics are correlated with behavioral scaling laws. Proc Natl Acad Sci U S A 110: 3585-3590.
80. Yu S, Yang H, Shriki O, Plenz D (2013) Universal organization of resting brain activity at the thermodynamic critical point. Front Syst Neurosci 7: 42.
81. Oliveira RG, Tanaka M, Maggio B (2005) Many length scales surface fractality in monomolecular films of whole myelin lipids and proteins. J Struct Biol 149: 158-169.
82. Oliveira RG, Schneck E, Funari SS, Tanaka M, Maggio B (2010) Equivalent aqueous phase modulation of domain segregation in myelin monolayers and bilayer vesicles. Biophys J 99: 1500-1509.
83. Brovchenko I, Oleinikova A (2008) Interfacial and confined water. Elsevier Science, Amsterdam, The Netherlands.
84. Tishler M, Shoenfeld Y (2004) Vaccination may be associated with autoimmune diseases. Isr Med Assoc J 6: 430-432.
85. Dietert RR (2009) Distinguishing environmental causes of immune dysfunction from pediatric triggers of disease. Open Pediatr Med J 3: 38-44.
86. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA (2005) Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57: 67-81.
87. Gallez D, Coakley WT (1986) Interfacial instability at cell membranes. Prog Biophys Mol Biol 48: 155-199.
88. Inoue I, Ishida N, Kobatake Y (1973) Studies of excitable membrane formed on the surface of protoplasmic drops isolated from Nitella. IV. Excitability of the drop membrane in various compositions of the external salt solution. Biochim Biophys Acta 330: 27-38.
89. Ueda T, Muratsugu M, Inoue I, Kobatake Y (1974) Structural changes of excitable membrane formed on the surface of protoplasmic drops isolated from Nitella. J Membr Biol 18: 177-186.
90. Gabriel B, Teissié J (1996) Proton long-range migration along protein monolayers and its consequences on membrane coupling. Proc Natl Acad Sci U S A 93: 14521-14525.
91. Selye H (1966) Thrombohemorrhagic Phenomena. Springfield, IL, USA.
92. Ling GN (2001) Life at the cell and below-cell level: The hidden history of a functional revolution in biology. Pacific Press: Melville, NY, USA.
93. Tsuchiya Y, Yamazaki H, Aoki T (1991) Steady and transient behaviors of protoplasmic streaming in Nitella internodal cell. Biophys J 59: 249-251.
94. Sivaguru M, Pike S, Gassmann W, Baskin TI (2003) Aluminum rapidly depolymerizes cortical microtubules and depolarizes the plasma membrane: evidence that these responses are mediated by a glutamate receptor. Plant Cell Physiol 44: 667-675.
95. Wylie SR, Chantler PD (2003) Myosin IIA drives neurite retraction. Mol Biol Cell 14: 4654-4666.
96. Ortiz PA, Garvin JL (2003) Trafficking and activation of eNOS in epithelial cells. Acta Physiol Scand 179: 107-114.
97. Förstermann U, Münzel T (2006) Endothelial nitric oxide synthase in vascular disease: From marvel to menace. Circulation 113: 1708-1714.
98. Kleinbongard P, Schulz R, Rassaf T, Lauer T, Dejam A, et al. (2006) Red blood cells express a functional endothelial nitric oxide synthase. Blood 107: 2943-2951.
99. Hickner RC, Kemeny G, Stallings HW, Manning SM, McIver KL (2006) Relationship between body composition and skeletal muscle eNOS. Int J Obes (Lond) 30: 308-312.
100. Hickner RC, Kemeny G, McIver K, Harrison K, Hostetler ME (2003) Lower skeletal muscle nutritive blood flow in older women is related to eNOS protein content. J Gerontol A Biol Sci Med Sci 58: 20-25.
101. Dinerman JL, Dawson TM, Schell MJ, Snowman A, Snyder SH (1994) Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc Natl Acad Sci U S A 91: 4214-4218.
102. Huang PL (2009) eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol Metab 20: 295-302.
103. Kolluru GK, Siamwala JH, Chatterjee S (2010) eNOS phosphorylation in health and disease. Biochimie 92: 1186-1198.
104. Aquilano K, Baldelli S, Rotilio G, Ciriolo MR (2008) Role of nitric oxide synthases in Parkinson's disease: A review on the antioxidant and anti-inflammatory activity of polyphenols. Neurochem Res 33: 2416-2426.
105. Atochin DN, Wang A, Liu VW, Critchlow JD, Dantas AP, et al. (2007) The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. J Clin Invest 117: 1961-1967.
106. Pozo D, Reiter RJ, Calvo JR, Guerrero JM (1997) Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J Cell Biochem 65: 430-442.
107. Asano K, Chee CB, Gaston B, Lilly CM, Gerard C, et al. (1994) Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci U S A 91: 10089-10093.
108. López-Figueroa MO, Møller M (1996) Nitric oxide synthase in the pineal gland. Histol Histopathol 11: 1089-1100.
109. Schaad NC, Vanecek J, Schulz PE (1994) Photoneural regulation of rat pineal nitric oxide synthase. J Neurochem 62: 2496-2499.
110. Moore Bd (2004) Bifunctional and moonlighting enzymes: Lighting the way to regulatory control. Trends Plant Sci 9: 221-228.
111. Seneff S, Lauritzen A, Davidson R, Lentz-Marino L (2012) Is endothelial nitric oxide synthase a moonlighting protein whose day job is cholesterol sulfate synthesis? Implications for cholesterol transport, diabetes and cardiovascular disease. Entropy 14: 2492-2530.
112. Kunz W (2010) Specific ion effects. World Scientific.
113. Bondy SC, Liu D, Guo-Ross S (1998) Aluminum treatment induces nitric oxide synthase in the rat brain. Neurochem Int 33: 51-54.
114. Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142.
115. Seneff S, Davidson RM, Liu J (2012) Is cholesterol sulfate deficiency a common factor in preeclampsia, autism, and pernicious anemia? Entropy 14: 2265-2290.
116. Bleau G, Bodley FH, Longpré J, Chapdelaine A, Roberts KD (1974) Cholesterol sulfate. I. Occurrence and possible biological function as an amphipathic lipid in the membrane of the human erythrocyte. Biochim Biophys Acta 352: 1-9.
117. du Plessis J, Ramachandran C, Weiner N, Müller DG (1996) The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage. Int J Pharm 127: 273-278.
118. Feingold KR, Jiang YJ (2011) The mechanisms by which lipids coordinately regulate the formation of the protein and lipid domains of the stratum corneum: Role of fatty acids, oxysterols, cholesterol sulfate and ceramides as signaling molecules. Dermatoendocrinol 3: 113-118.
119. Czech W, Stadler BM, Schôpf E, Kapp A (1995) IgE autoantibodies in atopic dermatitis-Occurrence of different antibodies against the CH3 and the CH4 epitopes of IgE. Allergy 50: 243-248.
120. Skinner JL, Pieniazek PA, Gruenbaum SM (2012) Vibrational spectroscopy of water at interfaces. Acc Chem Res 45: 93-100.
121. Murch SH, MacDonald TT, Walker-Smith JA, Levin M, Lionetti P, et al. (1993) Disruption of sulphated glycosaminoglycans in intestinal inflammation. Lancet 341: 711-714.
122. Bernfield M, Götte M, Park PW, Reizes O, Fitzgerald ML, et al. (1999) Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68: 729-777.
123. de la Monte SM, Wands JR (2008) Alzheimer's disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol 2: 1101-1113.
124. Seneff S, Davidson R, Mascitelli L (2012) Might cholesterol sulfate deficiency contribute to the development of autistic spectrum disorder? Med Hypotheses 78: 213-217.
125. Lander AD, Fujii DK, Gospodarowicz DK, Reichardt LF (1982) Characterization of a factor that promotes neurite outgrowth: Evidence linking activity to a heparan sulfate proteoglycan. J Cell Biol 94: 574-585.
126. Lauri SE, Kaukinen S, Kinnunen T, Ylinen A, Imai S, et al. (1999) Regulatory role and molecular interactions of a cell-surface heparan sulfate proteoglycan (N-syndecan) in hippocampal long-term potentiation. J Neurosci 19: 1226-1235.
127. Irie F, Badie-Mahdavi H, Yamaguchi Y (2012) Autism-like socio-communicative deficits and stereotypies in mice lacking heparan sulfate. Proc Natl Acad Sci U S A 109: 5052-5056.
128. Mercier F, Kwon YC, Douet V (2012) Hippocampus/amygdala alterations, loss of heparan sulfates, fractones and ventricle wall reduction in adult BTBR T+ tf/J mice, animal model for autism. Neurosci Lett 506: 208-213.
129. Pearson BL, Corley MJ, Vasconcellos A, Blanchard DC, Blanchard RJ (2013) Heparan sulfate deficiency in autistic postmortem brain tissue from the subventricular zone of the lateral ventricles. Behav Brain Res 243: 138-145.
130. Han X, M Holtzman D, McKeel DW Jr, Kelley J, Morris JC (2002) Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J Neurochem 82: 809-818.
131. Edwards DJ, Altman HJ, Galinsky RE (1993) Plasma concentrations of inorganic sulfate in Alzheimer's disease. Neurology 43: 1837-1838.
132. Siegel N, Haug A (1983) Aluminum interaction with calmodulin. Evidence for altered structure and function from optical and enzymatic studies. Biochim Biophys Acta 744: 36-45.
133. Galvin GE (2010) Fluoride, when complexed with aluminum, mimics the-phosphate of GTP causing false activation of the G-protein cascade and amplification of inflammatory molecules. MS Thesis, Biomedical Sciences Department, School of Health Professions and Nursing Long Island University, Long Island, NY, USA.
134. Coleman DE, Berghuis AM, Lee E, Linder ME, Gilman AG, et al. (1994) Structures of active conformations of Gi alpha 1 and the mechanism of GTP hydrolysis. Science 265: 1405-1412.
135. Rosen LN, Targum SD, Terman M, Bryant MJ, Hoffman H, et al. (1990) Prevalence of seasonal affective disorder at four latitudes. Psychiatry Res 31: 131-144.
136. Lewy AJ, Bauer VK, Cutler NL, Sack RL, Ahmed S, et al. (1998) Morning vs evening light treatment of patients with winter depression. Arch Gen Psychiatry 55: 890-896.
137. Lang SB, Marino AA, Berkovic G, Fowler M, Abreo KD (1996) Piezoelectricity in the human pineal gland. Bioclectrochem Bioenerg 41: 191-195.
138. Osredkar J, Zenko B, Grum DK, Krsnik M, Dzeroski S, et al. (2005) Analysis of the relationship between pineal hormone melatonin level and occupational mercury exposure in ex-miners with machine learning methods. Metodoloski zvezki 2: 161-172.
139. Abu-Taweel GM, Ajarem JS, Ahmad M (2012) Neurobehavioral toxic effects of perinatal oral exposure to aluminum on the developmental motor reflexes, learning, memory and brain neurotransmitters of mice offspring. Pharmacol Biochem Behav vior 101: 49-56.
140. Esparza JL, Gómez M, Rosa Nogués M, Paternain JL, Mallol J, et al. (2005) Melatonin reduces oxidative stress and increases gene expression in the cerebral cortex and cerebellum of aluminum-exposed rats. J Pineal Res 39: 129-136.
141. Schaad NC, Vanecek J, Schulz PE (1994) Photoneural regulation of rat pineal nitric oxide synthase. J Neurochem 62: 2496-2499.
142. Kuberan B, Lech M, Borjigin J, Rosenberg RD (2004) Light-induced 3-O-sulfotransferase expression alters pineal heparan sulfate fine structure. A surprising link to circadian rhythm. J Biol Chem 279: 5053-5054.
143. Buu NT, Kuchel O (1979) The direct converstion of dopamine 3-O-sulfate to norepinephrine by dopamine-beta-hydroxylase. Life Sci 24: 783-789.
144. Mahlberg R, Walther S, Kalus P, Bohner G, Haedel S, et al. (2008) Pineal calcification in Alzheimer's disease: An in vivo study using computed tomography. Neurobiol Aging 29: 203-209.
145. Luke J (2001) Fluoride deposition in the aged human pineal gland. Caries Res 35: 125-128.
146. Blaylock RL (2004) Excitotoxicity: A possible central mechanism in fluoride toxicity. Fluoride 37: 301-314.
147. Good PF, Olanow CW, Perl DP (1992) Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study. Brain Res 593: 343-346.
148. Burnatowska-Hledin MA, Kaiser L, Mayor GH (1983) Aluminum, parathyroid hormone, and osteomalacia. Spec Top Endocrinol Metab 5: 201-226.
149. Alfrey AC, Hegg A, Craswell P (1980) Metabolism and toxicity of aluminum in renal failure. Am J Clin Nutr 33: 1509-1516.
150. Mayor GH, Burnatowska-Hledin MA (1983) Impaired renal function and aluminum metabolism. Fed Proc 42: 2979-2983.
151. Honda H, Sanada D, Akizawa T (2006) Vitamin D metabolism and chronic kidney disease. Clin calcium16: 1143-1146.
152. Mayor GH, Keiser JA, Makdani D, Ku PK (1977) Aluminum absorption and distribution: Effect of parathyroid hormone. Science 197: 1187-1189.
153. Mayor GH, Sprague SM, Hourani MR, Sanchez TV (1980) Parathyroid hormone-mediated aluminum deposition and egress in the rat. Kidney Int 17: 40-44.
154. Fernell E, Barnevik-Olsson M, Bågenholm G, Gillberg C, Gustafsson S, et al. (2010) Serum levels of 2 5-hydroxyvitamin D in mothers of Swedish and of Somali origin who have children with and without autism. Acta Paediatr 99: 743-747.
155. Meguid NA, Hashish AF, Anwar M, Sidhom G (2010) Reduced serum levels of 25-hydroxy and 1,25-dihydroxy vitamin D in Egyptian children with autism. J Altern Complement Med 16: 641-645.
156. Cannell JJ (2008) Autism and vitamin D. Med Hypotheses 70: 750-759.
157. Campbell A, Becaria A, Lahiri DK, Sharman K, Bondy SC (2004) Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain. J Neurosci Res 75: 565-572.
158. Krewski D, Yokel RA, Nieboer E, Borchelt D, Cohen J, et al. (2007) Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J Toxicol Environ Health B Crit Rev 10: 1-269.
159. Slatopolsky E (1998) The role of calcium, phosphorus and vitamin D metabolism in the development of secondary hyperparathyroidism. Nephrol Dial Transplant 3: 3-8.
160. Bosworth C, de Boer IH (2013) Impaired vitamin D metabolism in CKD. Semin Nephrol 33: 158-168.
161. Hillman LS, Rojanasathit S, Slatopolsky E, Haddad JG (1977) Serial measurements of serum calcium, magnesium, parathyroid hormone, calcitonin, and 25-hydroxy-vitamin D in premature and term infants during the first week of life. Pediatr Res 11: 739-744.
162. Bishop NJ, Morley R, Day JP, Lucas A (1997) Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions. N Engl J Med 336: 1557-1561.
163. Rashid G, Bernheim J, Green J, Benchetrit S (2007) Parathyroid hormone stimulates the endothelial nitric oxide synthase through protein kinase A and C pathways. Nephrol Dial Transplant 22: 2831-2837.
164. Hem SL, Hogenesch H (2007) Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation. Expert Rev Vaccines 6: 685-698.
165. Egan PM, Belfast MT, Giménez JA, Sitrin RD, Mancinelli RJ (2009) Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant-adsorbed hepatitis B vaccine. Vaccine 27: 3175-3180.
166. Matheis W, Zott A, Schwanig M (2001) The role of the adsorption process for production and control combined adsorbed vaccines. Vaccine 20: 67-73.
167. Crowther RS, Marriott C (1984) Counter-ion binding to mucus glycoproteins. J Pharm Pharmacol 36: 21-26.
168. Jouhanneau P, Raisbeck GM, Yiou F, Lacour B, Banide H, et al. (1997) Gastrointestinal absorption, tissue retention, and urinary excretion of dietary aluminum in rats determined by using 26Al. Clin Chem 43: 1023-1028.
169. Persy VP, Behets GJ, De Broe ME, D'Haese PC (2009) Management of hyperphosphatemia in patients with end-stage renal disease: focus on lanthanum carbonate. Int J Nephrol Renovasc Dis 2: 1-8.
170. Coburn JW, Mischel MG, Goodman WG, Salusky IB (1991) Calcium citrate markedly enhances aluminum absorption from aluminum hydroxide. Am J Kidney Dis 17: 708-711.
171. Negro R (2008) Selenium and thyroid autoimmunity. Biologics 2: 265-273.
172. Clapp T, Siebert P, Chen D, Jones Braun L (2011) Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability. J Pharm Sci 100: 388-401.
173. Iyer S, HogenEsch H, Hem SL (2003) Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production. Vaccine 21: 1219-1223.
174. Hansen B, Sokolovska A, HogenEsch H, Hem SL (2007) Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response. Vaccine 25: 6618-6624.
175. Iyer S, Robinett RS, HogenEsch H, Hem SL (2004) Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant. Vaccine 22: 1475-1479.
176. Delhaize E, Ryan PR (1995) Aluminum toxicity and tolerance in plants. Plant Physiol 107: 315-321.
177. Kirschbaum BB, Schoolwerth AC (1989) Acute aluminum toxicity associated with oral citrate and aluminum-containing antacids. Am J Med Sci 297: 9-11.
178. Rowland A, Grainger R, Smith RS, Hicks N, Hughes A (1990) Water contamination in North Cornwall: A retrospective cohort study into the acute and short-term effects of the aluminum sulphate incident in July 1988. J R Soc Health 110: 166-172.
179. Altmann P, Cunningham J, Dhanesha U, Ballard M, Thompson J, et al. (1999) Disturbance of cerebral function in people exposed to drinking water contaminated with aluminium sulphate: retrospective study of the Camelford water incident. BMJ 319: 807-811.
180. Coggon D (1991) Camelford revisited. BMJ 303: 1280-1281.
181. Bondy SC (2010) The neurotoxicity of environmental aluminum is still an issue. Neurotoxicology 31: 575-581.
182. Walton JR (2006) Aluminum in hippocampal neurons from humans with Alzheimer's disease. Neurotoxicology 27: 385-394.
183. Walton JR (2009) Functional impairment in aged rats chronically exposed to human range dietary aluminum equivalents. Neurotoxicology 30: 182-193.
184. Walton JR, Wang MX (2009) APP expression, distribution and accumulation are altered by aluminum in a rodent model for Alzheimer's disease. J Inorg Biochem 103: 1548-1554.
185. Warner JO (2007) Anaphylaxis; The latest allergy epidemic. Pediatr Allergy Immunol 18: 1-2.
186. Cauwels A, Janssen B, Buys E, Sips P, Brouckaert P (2006) Anaphylactic shock depends on PI3K and eNOS-derived NO. J Clin Invest 116: 2244-2251.
187. Walls RS (1977) Eosinophil response to alum adjuvants: Involvement of T Cells in non-antigen-dependent mechanisms. Proc Soc Exp Biol Med 156: 431-435.
188. Wang HB, Weller PF (2008) Pivotal advance: Eosinophils mediate early alum adjuvant-elicited B cell priming and IgM production. J Leukoc Biol 83: 817-821.
189. Wilkins T, Gillies RA, Thomas AM, Wagner PJ (2007) The prevalence of dysphagia in primary care patients: A Hames Net Research Network study. J Am Board Fam Med 20: 144-150.
190. Blanchard C, Rothenberg ME (2008) Basic pathogenesis of eosinophilic esophagitis. Gastrointest Endosc Clin N Am 18: 133-143.
191. Lucendo AJ, Sánchez-Cazalilla M (2012) Adult versus pediatric eosinophilic esophagitis: Important differences and similarities for the clinician to understand. Expert Rev Clin Immunol 8: 733-745.
192. Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, et al. (2007) Eosinophilic esophagitis in children and adults: A systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 133: 1342-1363.
193. Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, et al. (2011) Eosinophilic esophagitis: Updated consensus recommendations for children and adults. J Allergy Clin Immunol 128: 3-20.
194. Prasad GA, Alexander JA, Schleck CD, Zinsmeister AR, Smyrk TC, et al. (2009) Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol 7: 1055-1061.
195. Yakoot M (2011) Eosinophilic digestive disease (EDD) and allergic bronchial asthma; Two diseases or expression of one disease in two systems? Ital J Pediatr 37: 18.
196. Castilow EM, Meyerholz DK, Varga SM (2008) IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease. J Immunol 180: 2376-2384.
197. Howell MD, Fairchild HR, Kim BE, Bin L, Boguniewicz M, et al. (2008) Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol 128: 2248-2258.
198. O'Regan GM, Sandilands A, McLean WH, Irvine AD (2009) Filaggrin in atopic dermatitis. J Allergy Clin Immunol 124: R2-6.
199. Blanchard C, Stucke EM, Burwinkel K, Caldwell JM, Collins MH, et al. (2010) Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol 184: 4033-4041.
200. Weidinger S, O'Sullivan M, Illig T, Baurecht H, Depner M, et al. (2008) Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol 121: 1203-1209.
201. Long SA, Wertz PW, Strauss JS, Downing DT (1985) Human stratum corneum polar lipids and desquamation. Arch Dermatol Res 277: 284-287.
202. Purello-D'Ambrosio F, Gangemi S, Minciullo PL, Lombardo G, Ricciardi L, et al. (2000) Aluminium allergy in a patient with occupational contact dermatitis. Allergol Immunopathol (Madr) 28: 74-75.
203. Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, Howarth P, et al. (1993) Induction of nitric oxide synthase in asthma. Lancet 342: 1510-1513.
204. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, et al. (1994) Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343: 133-135.
205. Perkins DL (1998) T-cell activation in autoimmune and inflammatory diseases. Curr Opin Nephrol Hypertens 7: 297-303.
206. Chai B, Yoo H, Pollack GH (2009) Effect of radiant energy on near-surface water. J Phys Chem B 113: 13953-13958.
207. Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22: 477-501.
208. Alam ZI, Jenner A, Daniel SE, Lees AJ, Cairns N, et al. (1997) Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem 69: 1196-1203.
209. Sabuncu MR, Desikan RS, Sepulcre J, Yeo BT, Liu H, et al. (2011) The dynamics of cortical and hippocampal atrophy in Alzheimer disease. Arch Neurol 68: 1040-1048.
210. Boillée S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, et al. (2006) Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312: 1389-1392.
211. Yamaguchi T, Kanazawa I, Takaoka S, Sugimoto T (2011) Serum calcium is positively correlated with fasting plasma glucose and insulin resistance, independent of parathyroid hormone, in male patients with type 2 diabetes mellitus. Metabolism 60: 1334-1339.
212. McKane WR, Khosla S, Egan KS, Robins SP, Burritt MF, et al. (1996) Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption. J Clin Endocrinol Metab 81: 1699-1703.
213. Seneff S, Davidson RM, Liu J (2012) Empirical data confirm autism symptoms related to aluminum and acetaminophen exposure. Entropy 14: 2227-2253.